Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891263 · ClinicalTrials.gov registry record · NA
Suture-based, Minimally Invasive Technique Used to Correct NSD
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04891263: Clinical Trial NA study, sponsored by Stanford University.
NCT04891263 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04891263, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Nasal Septal Deviation (NSD) is one of the most common indications for surgery seen by ENT physicians, however, correction requires open surgery which is associated with several weeks of recovery. The purpose of this study is to elucidate whether a suture-based, minimally invasive technique can be used to safely and effectively address NSD.
Interventions
- PROCEDURE Suture-Septoplasty
- DEVICE Surgical suture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-08-02 |
| Est. Completion | 2021-09-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04891263
The ClinicalTrials.gov registry entry for NCT04891263 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Suture-Septoplasty is the first listed.
NCT04891263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04891263 about?
NCT04891263 is a clinical study titled "Suture-based, Minimally Invasive Technique Used to Correct NSD". Nasal Septal Deviation (NSD) is one of the most common indications for surgery seen by ENT physicians, however, correction requires open surgery which is associated with several weeks of recovery. The purpose of this study is to elucidate whether a suture-based, minimally invasive technique can be u...
What is the current status of trial NCT04891263?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2021-08-02. Estimated completion is 2021-09-13.
What interventions are being tested in trial NCT04891263?
The interventions under investigation include: Suture-Septoplasty (PROCEDURE), Surgical suture (DEVICE).
Who is sponsoring clinical trial NCT04891263?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.